Ibandronat Sandoz 150 mg filmom obložene tablete
| Name | Ibandronat Sandoz 150 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-758910209 |
| Active Substance | natrijev ibandronat hidrat |
| Composition | svaka filmom obložena tableta sadrži 150 mg ibandronatne kiseline (u obliku natrijevog ibandronat hidrata) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija Lek Pharmaceuticals d.d., Lendava, Slovenija Lek S.A., Varšava, Poljska Salutas Pharma GmbH, Barleben, Njemačka S.C. Sandoz S.R.L., Targu Mures, Rumunjska Pharmathen S.A., Pallini Attiki, Grčka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 24.11.2017 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/439 |
| Registration Number | 381-12-01/30-17-04 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | M05BA06 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
